Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study.
Saved in:
| Title: | Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study. |
|---|---|
| Authors: | Slotman E; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., Weijzen F; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands., Fransen HP; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van Hoeve JC; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Huijben AMT; Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands., Kuip EJM; Department of Medical Oncology and Department of Anesthesiology, Pain and Palliative Care, Radboud Medical Center, Nijmegen, Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Kunst PWA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., van Laarhoven HWM; Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Research Institute GROW, Maastricht University Medical Centre, Maastricht, Netherlands., Raijmakers NJH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van der Linden YM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Radiotherapy, Leiden University Medical Centre, Leiden, Netherlands.; Centre of Expertise in Palliative Care, Leiden University Medical Centre, Leiden, Netherlands., Siesling S; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands. |
| Corporate Authors: | On-behalf-of-the-COVID-and-Cancer-NL Consortium |
| Source: | International journal of cancer [Int J Cancer] 2024 May 15; Vol. 154 (10), pp. 1786-1793. Date of Electronic Publication: 2024 Jan 24. |
| Publication Type: | Observational Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.34857 |
